Research Antibodies Market Will Grow at a Steady Rate of 6.1% from 2014 to 2025: Grand View Research, Inc.
The
global research antibodies market size is expected to
reach USD 4.30 billion by 2025, according to a new report by Grand View
Research, Inc., expanding at a CAGR of 6.1% during the forecast period. The
market is predominantly driven by growing number of R&D collaborations
among various public and private organizations to promote technical
advancements in product development activities and disease progression studies.
Consistent recommendations and guidelines issued by regulatory organizations
for laboratories to facilitate generation of accurate results and ensure
high-quality standards are slated to enhance adoption of research antibodies
over the coming years. For instance, in May 2016, the International Society for
Stem Cell Research issued revised guidelines for cell-based therapies. The
revised guidelines were issued with a focus to improve overall efficiency and
quality of preclinical studies.
In
addition, prominent market players are entering into partnership with R&D entities
that are anticipated to open new avenues. In December 2016, Bayer AG and
Versant Ventures collaborated to invest around USD 225.0 million for the
establishment of a stem cell research facility in Canada to encourage
commercialization of regenerative medicine therapies. Increasing prevalence of
breast cancer and soaring need for personalized medicine is stirring up the
demand for advanced techniques, which in turn is creating ample growth
opportunities for the research antibodies market.
Browse full
research report on Research Antibodies Market: www.grandviewresearch.com/industry-analysis/research-antibodies-market
Further key
findings from the study suggest:
- Primary antibodies were the most prominent
product segment in 2016 owing to greater specificity leading to increased
adoption in research activities. The segment is expected to account for
more than 65.0% of the overall market revenue by 2025
- On the basis of type, monoclonal antibodies
captured substantial share of the market in 2016, owing to high
sensitivity for detection of antigens and efficient staining properties
with less background noise. The segment is anticipated to rise at a CAGR
of 6.6% during the forecast period
- Western blotting commanded the leading share in
the market, due to benefits such as better immunogenic response from infectious
agents and higher cost efficiency. The immunoprecipitation segment is
estimated to post the highest CAGR of just over 7.0% during the same
period
- Mouse antibodies are relatively easier to
produce and possess greater specificity, thus resulting in higher adoption
in R&D and accounting for the largest market share in 2016.
- Oncology accounted for over 36.0% of the
overall revenue in 2016 as a consequence of growing cancer population
- Pharmaceutical & biotechnology companies
will be the leading end users of research antibodies owing to increased
adoption in drug development and discovery. The segment is poised to
represent more than 61.0% of the overall revenue by 2025.
- Contract research organizations are likely to
be the most promising end-user segment during the forecast period owing to
greater cost efficiency
- North America will continue to be the dominant
revenue contributor throughout the forecast period owing to local presence
of various biotechnology & biopharmaceutical manufacturers striving to
compete in the market
- Some of the key players in the global arena are
Abcam PLC; Agilent Technologies; and Thermo Fisher Scientific, Inc. The
research antibodies market is moderately consolidated and highly
competitive due to low entry barriers.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global research antibodies market
on the basis of product, type, technology, source, application, end-use, and
region:
Research
Antibodies Product Outlook (Revenue, USD Million, 2014 - 2025)
- Primary
- Secondary
Research
Antibodies Type Outlook (Revenue, USD Million, 2014 - 2025)
- Monoclonal
Antibodies
- Polyclonal
Antibodies
Research
Antibodies Technology Outlook (Revenue, USD Million, 2014 - 2025)
- Immunohistochemistry
- Immunofluorescence
- Western
Blotting
- Flow
Cytometry
- Immunoprecipitation
- ELISA
- Others
Research
Antibodies Source Outlook (Revenue, USD Million, 2014 - 2025)
- Mouse
- Rabbit
- Goat
- Others
Research
Antibodies Application Outlook (Revenue, USD Million, 2014 - 2025)
- Infectious
Diseases
- Immunology
- Oncology
- Stem
Cells
- Neurobiology
- Others
Research
Antibodies End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Academic
& Research Institutes
- Contract
Research Organizations
- Pharmaceutical
& Biotechnology Companies
Research
Antibodies Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- Middle
East & Africa
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/industry-analysis/research-antibodies-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment